METHODS FOR TREATING MYOFASCIAL, MUSCLE, AND/OR BACK PAIN
The present disclosure is drawn to methods for treating myofascial pain, muscle pain, back pain, or combinations of these pains. Specifically, a method for treating myofascial pain, muscle pain, back pain, or combinations thereof includes the application of an analgesic system to a skin surface of a subject experiencing the pain and maintaining the analgesic system on the skin surface for a period of time of at least 30 minutes. The analgesic system applied to the skin surface can include a heating component and a local anesthetic formulation which includes at least one local anesthetic. The heating component can be capable of heating the skin surface to a temperature of 36° C. to 42° C.
1 . A method for treating myofascial pain, muscle pain, back pain, or combination thereof, comprising:
applying an analgesic system to a skin surface of a subject experiencing myofascial pain, muscle pain, back pain, or combination thereof;
maintaining the analgesic system on the skin surface for a period of time of at least 30 minutes;
wherein the analgesic system comprises i) a heating component capable of heating the skin surface to a temperature of 36° C. to 42° C. and ii) a local anesthetic formulation including at least one local anesthetic.
2 . The method of claim 1 , wherein the local anesthetic formulation includes lidocaine base.
3 . The method of claim 1 , wherein the local anesthetic includes formulation tetracaine base.
4 . The method of claim 1 , wherein the local anesthetic is a eutectic mixture of lidocaine base and tetracaine base.
5 . The method of claim 1 , wherein the local anesthetic is a eutectic mixture of lidocaine base and tetracaine base, and the weight percentage of the eutectic mixture is more than 30% of the weight of the local anesthetic formulation.
6 . The method of claim 1 , wherein the local anesthetic is selected from the group of tetracaine, lidocaine, prilocaine, ropivacaine, bupivacaine, benzocaine, and combinations thereof.
7 . The method of claim 1 , wherein the heating component is capable of heating the skin to a temperature of 36° C. to 42° C. for at least 30 minutes.
8 . The method of claim 1 , wherein the analgesic system is maintained on the skin surface for a period of time of at least 60 minutes.
9 . The method of claim 1 , wherein the analgesic system is maintained on the skin surface for a period of time of at least two hours.
10 . The method of claim 1 , wherein the local anesthetic formulation has a skin contact region having an area of about 2 cm 2 to about 200 cm 2 .
11 . The method of claim 1 , wherein the local anesthetic formulation has a skin contact region having an area of about 3 cm 2 to about 150 cm 2 .
12 . The method of claim 1 , wherein the local anesthetic formulation has a skin contact region having an area of about 5 cm 2 to about 130 cm 2 .
13 . The method of claim 1 , wherein the local anesthetic formulation has a skin contact region having an area of about 7 cm 2 to about 80 cm 2 .
14 . The method of claim 1 , wherein the local anesthetic formulation has a skin contact region having an area of about 8 cm 2 and about 40 cm 2 .
15 . The method of claim 1 , wherein the local anesthetic formulation has a skin contact region, said skin contact region having an area of about 8 cm 2 to about 13 cm 2 .
16 . The method of claim 1 , wherein the local anesthetic formulation comprises at least 30% by weight of a eutectic mixture of lidocaine base and tetracaine base and the analgesic system is maintained on the skin for a period of time of at least 30 minutes, and the local anesthetic formulation has a skin contact region having an area of about 8 cm 2 to about 13 cm 2 .